---
schema_version: "secwatch.filing_event.v1"
accession: "0001568651-24-000013"
form_type: "8-K"
ticker: "OSCR"
cik: "0001568651"
company_name: "Oscar Health, Inc."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T18:20:54.957872+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Oscar Health reports first-ever quarterly net income of $177.4M; revenue up 46% YoY

## Summary
- Q1 2024 net income of $177.4M ($0.62 diluted EPS) vs. net loss of $39.8M in Q1 2023.
- Total revenue of $2.1B, up 46% YoY driven by higher membership and pricing.
- Medical Loss Ratio improved 210 bps YoY to 74.2%; SG&A Expense Ratio improved 870 bps to 18.4%.
- Adjusted EBITDA of $219.3M, up $168.2M YoY; total members reached 1,448,408.
- Company reaffirms full-year 2024 outlook across all metrics.

## SEC filing metadata
- accession: 0001568651-24-000013
- form_type: 8-K
- ticker: OSCR
- cik: 0001568651
- company_name: Oscar Health, Inc.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1568651/000156865124000013/0001568651-24-000013-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1568651/000156865124000013/oscr-20240507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001568651-24-000013
- JSON: https://secwatch.observer/filing/0001568651-24-000013.json
- Plain text: https://secwatch.observer/filing/0001568651-24-000013.txt

## Key facts
- Earnings Releases
  Oscar Health, Inc. reported First Quarter 2024 results: revenue $2.1 billion, net income $177.4 million, EPS $0.62. Guidance reaffirmed.
  - Period: First Quarter 2024
  - Revenue: $2.1 billion
  - Net income: $177.4 million
  - EPS: $0.62
  - Guidance: reaffirmed
  - Result: reported results
  source text: Oscar Health, Inc. ir.hioscar.com News Release Oscar Health Announces Results for First Quarter 2024 May 7, 2024 • For the quarter ended March 31, 2024: ◦ Total Revenue of $2.1 billion, a 46% increase YoY ◦ Medical Loss Ratio of 74.2%, a 210 bps improvement YoY ◦ SG&A Expense Ratio of 18.4%, an 870 bps improvement YoY ◦ Net Income attributable to Oscar of $177.4 million, or $0.62 of diluted earnings per share, a $217.1 million improvement YoY
  evidence_url: https://www.sec.gov/Archives/edgar/data/1568651/000156865124000013/0001568651-24-000013-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.